Verily, the life sciences business of Google parent company Alphabet, has a new prototype for shoes enabled with sensors that can help track weight, falls and movement, according to CNBC.
Verily has reportedly been looking for partners to develop the shoes, showing a prototype in private meetings in the hopes of bringing them to market, three people familiar with the project told CNBC.
The project is the latest example of the arms race in digital health from major companies, such as Apple and Amazon. Verily’s Study Watch recently earned FDA clearance for its electrocardiogram (ECG) feature. The Alphabet subsidiary also raised $1 billion in an investment round at the start of the year.
See the full story below:
Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."